Remdesivir did not cut hospital stay or mortality in COVID-19 patients, WHO says
The results are from WHO's “Solidarity” trial, which evaluated the effects of four potential drug regimens.
Full Article
Remdesivir did not cut hospital stay or mortality in COVID-19 patients, WHO says
Hindu
0 shares
1 views
You might like
Related news coverage
Remdesivir trial results stumps desi medicos
Mid-Day
Doctors from across the city have raised serious concerns regarding the World Health Organisation's (WHO) recent findings of the..
-
Supreme Court takes into account WHO report on Remdesivir, seeks Centre's response
Mid-Day
-
US gives full approval for antiviral remdesivir drug to treat COVID-19 patients
Mid-Day
-
Remdesivir, Hydroxychloroquine Have Little or No Effect on Severe COVID-19 Cases, WHO Says
VOA News
-
Remdesivir has little effect on hospital stay or mortality in COVID-19 patients, WHO study finds
CBC.ca
Advertisement
More coverage
WHO says Remdesivir has little or no effect on COVID-19 patients
Zee News
WHO study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among..